Clinical trial · Interventional
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
A Phase III Randomized Placebo Controlled and Double Blinded Study of IM862 for Patients With Muco-Cutaneous AIDS Associated Kaposi's Sarcoma
NCT00002445CI-TRIAL-00000089completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to see if it is safe and effective to use IM862 to treat Kaposi's sarcoma (KS) in AIDS patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HIV Infections | — | UNRESOLVED | — |
| Sarcoma, Kaposi | Kaposi Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| IM862 | Drug | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria Patients may be eligible for this study if they: * Are HIV-positive. * Have AIDS-related Kaposi's sarcoma. * Have at least 5 skin or mouth sores that do not require chemotherapy. * Have been taking anti-HIV drugs for at least 8 weeks before study entry with no changes in the regimen. * Are at least 18 years old. * Agree to practice effective methods of birth control. Exclusion Criteria Patients will not be eligible for this study if they: * Have an AIDS-related opportunistic infection (except for genital herpes) within 2 weeks of study entry. * Have had another type of cancer within the past 2 years (except for certain types of skin cancer, cervical cancer, or anal cancer). * Have a severe chest cold. * Have certain other serious medical conditions. * Have received certain medications, including chemotherapy, within the past 4 weeks. * Abuse alcohol or drugs. * Are pregnant or breast-feeding.
References
Publications (0)
Data not yet available
No reference posted for this study.